About The Medical Condition ORF-15927

ClusterMed

Find the definition of the medical term ORF-15927. ORF-15927 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.

ORF-15927

ORF-15927 Medical Condition Defined & Explained
ORF-15927 Medical Condition

What's The Definition Of The Medical Condition ORF-15927?

A synthetic methylprostaglandin E1 analog that reduces gastric acid secretion and enhances the gastric mucus-bicarbonate barrier. It is effective in the therapy of gastric ulcers and gives significant protection against NSAID-induced gastric mucosal damage. The drug also prevents cyclosporin A-induced damage to endocrine and exocrine pancreatic secretions. It shows a low order of acute toxicity and there is no evidence of embryotoxicity, fetotoxicity, teratogenicity, or mutagenicity in animal studies.

More Medical Conditions

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Medical Conditions Definitions Of The Day